Skip to main content

HIV Vaccine Breakthroughs: Who Pays?

Anthony Canamucio In and outside his territories and dominions ... and with his far off neighbors, Priyadarsi has arranged for the medical treatment of man and beast. He has caused herbs, roots and fruits to be imported, wells to be dug and trees to be planted on the roadside for the enjoyment of men and animals. --Edits of Asoka, third century BC, inscribed on a rock in Girnar, Gujarat, India On occasion, an ethical consensus may be reached only to unravel as the question of "who pays" be

Written byArthur Ammann
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00

In and outside his territories and dominions ... and with his far off neighbors, Priyadarsi has arranged for the medical treatment of man and beast. He has caused herbs, roots and fruits to be imported, wells to be dug and trees to be planted on the roadside for the enjoyment of men and animals.

--Edits of Asoka, third century BC, inscribed on a rock in Girnar, Gujarat, India

On occasion, an ethical consensus may be reached only to unravel as the question of "who pays" becomes a reality. This is precisely the issue facing the sponsors of HIV vaccine clinical trials in developing countries concerning the treatment of vaccine breakthroughs--individuals who become infected after immunization because the vaccine failed to protect them.

Prior to the advent of potent antiretroviral therapy (ART), HIV vaccine trials offered an opportunity to study both the efficacy of an HIV vaccine and the potential to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo